CIK 0001130598
- Non-accelerated filer
- Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-07-30 | Bienen Henry S Director | Conversion | +6,868 | 6,868 | ||
| 2013-07-30 | Bienen Henry S Director | Purchase | +6,667 | $15.00 | $100K | 13,535 |
| 2013-07-30 | Bienen Henry S Director | Conversion · Series I Convertible Preferred Stock | −9,156 | 0 | ||
| 2013-07-30 | Altland James SVP, Finance & Corp. Develop. | Exercise or conversion | +5,000 | $6.00 | $30K | 5,000 |
| 2013-07-30 | Altland James SVP, Finance & Corp. Develop. | Exercise or conversion · Stock Option (right to purchase) | −5,000 | 55,015 | ||
| 2013-07-30 | MCKEARN THOMAS J President, R&D | Purchase | +3,333 | $15.00 | $50K | 3,333 |
| 2013-07-30 | BANSAL AJAY Chief Financial Officer | Conversion | +23,785 | 43,846 | ||
| 2013-07-30 | BANSAL AJAY Chief Financial Officer | Conversion · Series B Convertible Preferred Stock | −28,181 | 0 | ||
| 2013-07-30 | Baxter Healthcare SA 10% owner | Conversion | +2,273,295 | 2,273,295 | ||
| 2013-07-30 | Baxter Healthcare SA 10% owner | Purchase | +330,000 | $15.00 | $5.0M | 2,603,295 |
| 2013-07-30 | Baxter Healthcare SA 10% owner | Conversion · Series J Convertible Preferred Stock | −3,030,303 | 0 | ||
| 2013-07-25 | Reddy E Premkumar Director | Purchase | +300 | $22.71 | $7K | 1,273,018 |
| 2013-07-25 | Reddy E Premkumar Director | Purchase | +700 | $22.73 | $16K | 1,273,718 |
| 2013-07-25 | MCKEARN THOMAS J President, R&D | Grant or award · Stock Option (right to purchase) | +5,000 | 5,000 | ||
| 2013-07-25 | MCKEARN THOMAS J President, R&D | Grant or award · Stock Option (right to purchase) | +30,000 | 30,000 | ||
| 2013-07-25 | MEHTA VIREN Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2013-07-25 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +5,000 | 5,000 | ||
| 2013-07-25 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +100,000 | 100,000 | ||
| 2013-07-25 | Hoffman Michael B Director | Grant or award · Stock Option (right to purchase) | +13,000 | 13,000 | ||
| 2013-07-25 | GROOPMAN JEROME Director | Grant or award · Stock Option (right to purchase) | +20,000 | 20,000 |
Page 29 of 30 · 590 trades